The mycelium and fermentation broth (600 mL) was extracted by adding acetone (600 mL) and shaking at 220 rpm for 2 h. After filtration, the acetone extract was concentrated under reduced pressure to a final volume of 600 mL (100% water). The aqueous residue was loaded onto a SP207ss resin column (65 g, 32 × 100 mm) and eluted with an acetone/H2O stepped gradient (10/90 for 6 min, 20/80 for 6 min, 40/60 for 6 min, 60/40 for 6 min, 80/20 for 6 min and 100/0 for 12 min, 10 mL/min, 20 mL/fraction) to give nineteen fractions. Target metabolites were identified by LCMS in these fractions. An aliquot (300 μL) of fraction FS010 was subjected to semi-preparative reversed phase HPLC (Zorbax SB-C18 column, 9.4 × 250 mm, 5 μm, 3.6 mL/min, UV detection at 210 and 280 nm) eluting with CH3CN: H2O, linear gradient from 5 to 100% CH3CN in 63 min to yield a mixture of compounds 9 and 12 (tR 26 min) and compound 10 (tR 30 min). Fractions FS011 to FS014 were pooled and subjected to preparative reversed-phase HPLC (Zorbax SB-C18 PrepHT, 21.2 × 250 mm, 7 μm, 16 mL/min, UV detection at 210 and 280 nm) using H2O + 0.1% TFA (solvent A) and CH3CN + 0.1% TFA (solvent B), isocratic conditions of 5% B for 5 min and then a linear gradient from 5% to 100% B in 43 min to yield a fraction containing compound 11 (tR 28 min) and major impurities.
Compounds 9 and 10 have been previously reported as metabolites obtained by transformation of hydralazine by rat liver microsomes [1] as well as main products formed in human saliva and under gastric conditions when this drug was administered to patients suffering from hypertension [2] .
The identification of compound 12 was straightforward from the molecular formula and proton and 2D-NMR spectra. Compound 12 displayed a pseudomolecular ion at m/z 245.1282 (calc. for [M + H] + 245.1206) corresponding to a molecular formula of C14H16N2O2 suggesting a diketopiperazine nature for the compound. The presence of a proline moiety was inferred from signals attributed to the presence of three broad methylene multiplets in the proton spectrum (δH 3.31-3.35 and 3.51-3.57 (C-3) , δH 1.60-1.69 and 1.88-1.93 (C-4) and δH 1.60-1.69 and 2.01-2.06 (C-5)) and by H-H correlations observed in the COSY experiment. Proton in alpha for proline amino acid presents a chemical shift of 2.60-2.63 ppm that is significantly different to that expected for an amino acid alpha proton. This upfield shift could be due to a conformational arrangement of the aromatic ring that leaves this proton closer to its inner part. Analysis of the NMR spectra also indicated that phenylalanine was the second amino acid residue, showing signals of methylene benzylic protons at δH 2.99 and 3.19 respectively (C-10) attached to a monosubstituted aromatic ring (δH 7.18-7.31) . A proton at 4.20 ppm is attributed to the alpha proton for phenylalanine residue. Figure S3 . Hydralazine HSQC.
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